ALN-INHBE

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameALN-INHBE
Drug Alias NameALN-INHBE
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionInhibin beta E chain inhibitors
TargetsInhibin beta E chain
Therapy Area/IndicationsOverweight
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlnylam Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlnylam Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsOverweight
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A